AccuGel 29:1 is a stabilized, ready-to-use resolution of 40% (w/v) acrylamide : bisacrylamide(29:1). AccuGel 29:1 has zero acrylic acid content material, eliminating the mounted fees that trigger band streaking. Moreover, oxidation merchandise similar to aldehydes have been eliminated by a selective adsorption course of. With AccuGel 29:1, you possibly can belief that your outcomes might be constant from one electrophoretic run to the subsequent.
Improved Security
AccuGel 29:1 reduces publicity to neurotoxic acrylamide mud by eliminating the necessity for dealing with and weighing stable acrylamide and methylene bisacrylamide, which regularly results in airborne particulate that may be readily inhaled. On your safety, AccuGel 29:1 is equipped in PVC coated shatter-proof bottles.
Steady and Pure
AccuGel 29:1 is secure for 24 months when saved tightly capped in a darkish space at room temperature. Potential Well being ResultsInhalation
Inhalation of mist causes irritation to the respiratory tract. Signs could parallel ingestion. Ingestion
Poisonous! Could trigger systemic poisoning. Could trigger drowsiness, tingling sensations, fatigue, weak spot, stumbling, slurred speech, and shaking.
Could trigger central and peripheral nervous system harm. Extreme intoxication could trigger everlasting nerve harm. Could have an effect on reproductive
system and act as a teratogen.
Accu Gels
Pores and skin
Could trigger irritation and redness. Could be absorbed by the pores and skin inflicting systemic poisoning; signs could parallel ingestion. Eyes
Acrylamide options could trigger eye irritation. Carcinogenicity
Acrylamide is suspected as a most cancers hazard. Could trigger most cancers. Listed by NTP as a suspected carcinogen. Acrylamide is understood to the State of California to trigger most cancers. Mutagenicity
Acrylamide was damaging within the Ames assay each with and with out metabolic activation. Reproductive Toxicity
Acrylamide induced male reproductive toxicity has been demonstrated in Lengthy-Evans rats the place given better than or equal to 15 mg/kg/day acrylamide orally by gavage for 5 consecutive days. On this research, males receiving better than or equal to 15 mg/kg/day acrylamide had a decreased fertility index.
